Tag: Marc Voigt
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.Â
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
